CLIMB BIO, INC. Tax Credit Carryforward, Amount
CLIMB BIO, INC. (CLYM) had Tax Credit Carryforward, Amount of $2.02 million as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2024-03-28
- 2023-12-31: Tax Credit Carryforward, Amount $2.02M.
- 2022-12-31: Tax Credit Carryforward, Amount $6.49M.
- 2021-12-31: Tax Credit Carryforward, Amount $6.52M.
- 2020-12-31: Tax Credit Carryforward, Amount $2.63M.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2023-12-31 | $2.02M 10-K · filed 2024-03-28 |
| 2022-12-31 | $6.49M 10-K · filed 2024-03-28 |
| 2021-12-31 | $6.52M 10-K · filed 2024-03-28 |
| 2020-12-31 | $2.63M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |